Q-C Technologies Inc., a company operating within the Health Care sector, specifically in the Health Care Equipment & Supplies industry, has been a subject of interest in recent financial analyses. As of October 16, 2025, the company’s stock closed at $4.39 on the Nasdaq exchange. This figure is notably low compared to its 52-week high of $180, recorded on October 27, 2024. The significant drop in stock price is further highlighted by its 52-week low of $3.24, observed on September 4, 2025.

The company’s market capitalization stands at $9,420,000 USD, reflecting its current valuation in the market. However, the financial metrics indicate some challenges, particularly with a Price Earnings (P/E) ratio of -0.014. This negative P/E ratio suggests that the company is currently not generating profits, which could be a concern for investors seeking positive earnings growth.

Q-C Technologies Inc. is part of the broader health care industry, which includes companies like MyMD Pharmaceuticals Inc. MyMD Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing drug products aimed at treating aging and age-related diseases, chronic pain, anxiety, and sleep disorders. As a global entity, MyMD Pharmaceuticals serves a worldwide customer base with its extensive range of health care equipment and supplies. Investors interested in the health care sector can explore opportunities with MyMD Pharmaceuticals by visiting their website at www.mymd.com or trading their stocks on the Nasdaq.

The financial performance and market position of Q-C Technologies Inc. are critical for stakeholders to monitor, especially given the volatile nature of the health care equipment and supplies industry. The company’s ability to navigate these challenges and potentially return to profitability will be key factors in its future growth and stability in the market.